J. L. Fahey, J. M. G. Taylor, R. Detels, et al., “The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1,” The New England Journal of Medicine, Vol. 322, No. 3, 1990, pp. 166-172. doi:10.1056/NEJM199001183220305
 J. P. Phair, A. Munoz, R. Detels, et al., “The Risk of Pneumocystis carinii Pneumonia among Men Infected with Human Immunodeficiency Virus Type 1,” The New England Journal of Medicine, Vol. 322, No. 3, 1990, pp. 161-165. doi:10.1056/NEJM199001183220304
 J. E. Kaplan, H. Masur and K. K. Holmes, “Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America,” MMWR—Recommendations and Reports, 51 (RR08), 14 June 2002, pp. 1-46.
 C. A. Benson, J. E. Kaplan, H. Masur, A. Pau and K. K. Holmes, “Treating Opportunistic Infections among HIV-Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America,” MMWR—Recommendations and Reports, 53 (RR15), 17 December 2004, pp. 1-112.
 J. A. Aberg, J. E. Gallant, J. Anderson, et al., “Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America,” Clinical Infectious Diseases, Vol. 39, No. 5, 2004, pp. 609-629. doi:10.1086/423390
 L. A. Mandell, R. G. Wunderink, A. Anzueto, et al., “Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults,” Clinical Infectious Diseases, Vol. 44, Suppl. 2, 2007, pp. S27-S72. doi:10.1086/511159
 R. C. Williams Jr., F. T. Koster and K. A. Kilpatrick, “Alterations in Lymphocyte Cell Surface Markers during Various Human Infections,” The American Journal of Medicine, Vol. 75, No. 5, 1983, pp. 807-816. doi:10.1016/0002-9343(83)90412-6
 R. Seng, C. Goujard, L. Desquilbet, M. Sinet, C. Rouzioux, C. Deveau, F. Boufassa, J. F. Delfraissy, L. Meyer, A. Venet and The ANRS PRIMO and SEROCO Study Groups, “Rapid CD4+ Cell Decrease after Transient cART Initiated during Primary HIV Infection (ANRS PRIMO and SEROCO Cohorts),” Journal of Acquired Immune Deficiency Syndromes, Vol. 49, No. 3, 2008, pp. 251-258. doi:10.1097/QAI.0b013e318189a739